Global Vascular Stents
Global Vascular Stents

Vascular Stents Comprehensive Study by Type (Coronary Stents, Peripheral Stents, Carotid Stents, Renal Artery Stents, Femoral Stents, Iliac Stents, Other Peripheral stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), Application (Hospital, Clinic), (), Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), Material (Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Other Stents) Players and Region - Global Market Outlook to 2025

Vascular Stents Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Dec 2020 Edition 220 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Vascular Stents Market?

Vascular stents are small tubular scaffolds widely used in the treatment of arterial stenosis (narrowing of the vessel) to prevent acute vessel closure and late restenosis in a variety of vessels such as coronary arteries. Covered stents are composed of fabric or graft material, such as polytetrafluoroethylene (PTFE), covering a metal stent. They have various clinical applications in peripheral arterial disease management. Applications include treatment of atherosclerotic disease, sealing iatrogenic vessel perforations or ruptures, exclusion of aneurysms and pseudoaneurysms, treatment of arteriovenous fistulae, and management of failing dialysis grafts. Several covered stents are commercially available, including both self-expanding and balloon-expandable varieties

The market study is being classified by Type (Coronary Stents, Peripheral Stents, Carotid Stents, Renal Artery Stents, Femoral Stents, Iliac Stents, Other Peripheral stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm), by Application (Hospital and Clinic) and major geographies with country level break-up.

Medtronic plc (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India) and Vascular Concepts (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are C. R. Bard (United States), Endologix Inc. (United States), Lombard Medical Technologies (United Kingdom), Translumina GmbH (Germany) and JOTEC GmbH (Germany).

The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Vascular Stents market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Vascular Stents market by Type, Application and Region.

On the basis of geography, the market of Vascular Stents has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.






Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Vascular Stents Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Coronary Stents
  • Peripheral Stents
  • Carotid Stents
  • Renal Artery Stents
  • Femoral Stents
  • Iliac Stents
  • Other Peripheral stents
  • EVAR Stent Grafts
  • Abdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm
By Application
  • Hospital
  • Clinic
By Mode of Delivery
  • Balloon-expandable Stents
  • Self-expanding Stents

By Material
  • Metallic Stents
  • Cobalt-Chromium
  • Platinum Chromium
  • Nickel Titanium
  • Stainless Steel
  • Other Stents

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Factor Analysis
    • 3.1. Porters Five Forces
    • 3.2. Supply/Value Chain
    • 3.3. PESTEL analysis
    • 3.4. Market Entropy
    • 3.5. Patent/Trademark Analysis
  • 4. Global Vascular Stents, by Type, Application, , Mode of Delivery, Material and Region (value) (2014-2019)
    • 4.1. Introduction
    • 4.2. Global Vascular Stents (Value)
      • 4.2.1. Global Vascular Stents by: Type (Value)
        • 4.2.1.1. Coronary Stents
        • 4.2.1.2. Peripheral Stents
        • 4.2.1.3. Carotid Stents
        • 4.2.1.4. Renal Artery Stents
        • 4.2.1.5. Femoral Stents
        • 4.2.1.6. Iliac Stents
        • 4.2.1.7. Other Peripheral stents
        • 4.2.1.8. EVAR Stent Grafts
        • 4.2.1.9. Abdominal Aortic Aneurysm
        • 4.2.1.10. Thoracic Aortic Aneurysm
      • 4.2.2. Global Vascular Stents by: Application (Value)
        • 4.2.2.1. Hospital
        • 4.2.2.2. Clinic
      • 4.2.3. Global Vascular Stents by: Material (Value)
        • 4.2.3.1. Metallic Stents
        • 4.2.3.2. Cobalt-Chromium
        • 4.2.3.3. Platinum Chromium
        • 4.2.3.4. Nickel Titanium
        • 4.2.3.5. Stainless Steel
        • 4.2.3.6. Other Stents
      • 4.2.4. Global Vascular Stents Region
        • 4.2.4.1. South America
          • 4.2.4.1.1. Brazil
          • 4.2.4.1.2. Argentina
          • 4.2.4.1.3. Rest of South America
        • 4.2.4.2. Asia Pacific
          • 4.2.4.2.1. China
          • 4.2.4.2.2. Japan
          • 4.2.4.2.3. India
          • 4.2.4.2.4. South Korea
          • 4.2.4.2.5. Taiwan
          • 4.2.4.2.6. Australia
          • 4.2.4.2.7. Rest of Asia-Pacific
        • 4.2.4.3. Europe
          • 4.2.4.3.1. Germany
          • 4.2.4.3.2. France
          • 4.2.4.3.3. Italy
          • 4.2.4.3.4. United Kingdom
          • 4.2.4.3.5. Netherlands
          • 4.2.4.3.6. Rest of Europe
        • 4.2.4.4. MEA
          • 4.2.4.4.1. Middle East
          • 4.2.4.4.2. Africa
        • 4.2.4.5. North America
          • 4.2.4.5.1. United States
          • 4.2.4.5.2. Canada
          • 4.2.4.5.3. Mexico
  • 5. Vascular Stents: Manufacturers/Players Analysis
    • 5.1. Competitive Landscape
      • 5.1.1. Market Share Analysis
        • 5.1.1.1. Top 3
        • 5.1.1.2. Top 5
    • 5.2. Peer Group Analysis (2019)
    • 5.3. BCG Matrix
    • 5.4. Company Profile
      • 5.4.1. Medtronic plc (Ireland)
        • 5.4.1.1. Business Overview
        • 5.4.1.2. Products/Services Offerings
        • 5.4.1.3. Financial Analysis
        • 5.4.1.4. SWOT Analysis
      • 5.4.2. Abbott Laboratories (United States)
        • 5.4.2.1. Business Overview
        • 5.4.2.2. Products/Services Offerings
        • 5.4.2.3. Financial Analysis
        • 5.4.2.4. SWOT Analysis
      • 5.4.3. Boston Scientific Corporation (United States)
        • 5.4.3.1. Business Overview
        • 5.4.3.2. Products/Services Offerings
        • 5.4.3.3. Financial Analysis
        • 5.4.3.4. SWOT Analysis
      • 5.4.4. BIOTRONIK SE & Co. KG (Germany)
        • 5.4.4.1. Business Overview
        • 5.4.4.2. Products/Services Offerings
        • 5.4.4.3. Financial Analysis
        • 5.4.4.4. SWOT Analysis
      • 5.4.5. B. Braun Melsungen AG (Germany)
        • 5.4.5.1. Business Overview
        • 5.4.5.2. Products/Services Offerings
        • 5.4.5.3. Financial Analysis
        • 5.4.5.4. SWOT Analysis
      • 5.4.6. Terumo Corporation (Japan)
        • 5.4.6.1. Business Overview
        • 5.4.6.2. Products/Services Offerings
        • 5.4.6.3. Financial Analysis
        • 5.4.6.4. SWOT Analysis
      • 5.4.7. STENTYS SA (France)
        • 5.4.7.1. Business Overview
        • 5.4.7.2. Products/Services Offerings
        • 5.4.7.3. Financial Analysis
        • 5.4.7.4. SWOT Analysis
      • 5.4.8. MicroPort Scientific Corporation (China)
        • 5.4.8.1. Business Overview
        • 5.4.8.2. Products/Services Offerings
        • 5.4.8.3. Financial Analysis
        • 5.4.8.4. SWOT Analysis
      • 5.4.9. Meril Life Sciences Pvt. Ltd. (India)
        • 5.4.9.1. Business Overview
        • 5.4.9.2. Products/Services Offerings
        • 5.4.9.3. Financial Analysis
        • 5.4.9.4. SWOT Analysis
      • 5.4.10. Vascular Concepts (India)
        • 5.4.10.1. Business Overview
        • 5.4.10.2. Products/Services Offerings
        • 5.4.10.3. Financial Analysis
        • 5.4.10.4. SWOT Analysis
  • 6. Global Vascular Stents Sale, by Type, Application, , Mode of Delivery, Material and Region (value) (2020-2025)
    • 6.1. Introduction
    • 6.2. Global Vascular Stents (Value)
      • 6.2.1. Global Vascular Stents by: Type (Value)
        • 6.2.1.1. Coronary Stents
        • 6.2.1.2. Peripheral Stents
        • 6.2.1.3. Carotid Stents
        • 6.2.1.4. Renal Artery Stents
        • 6.2.1.5. Femoral Stents
        • 6.2.1.6. Iliac Stents
        • 6.2.1.7. Other Peripheral stents
        • 6.2.1.8. EVAR Stent Grafts
        • 6.2.1.9. Abdominal Aortic Aneurysm
        • 6.2.1.10. Thoracic Aortic Aneurysm
      • 6.2.2. Global Vascular Stents by: Application (Value)
        • 6.2.2.1. Hospital
        • 6.2.2.2. Clinic
      • 6.2.3. Global Vascular Stents by: Material (Value)
        • 6.2.3.1. Metallic Stents
        • 6.2.3.2. Cobalt-Chromium
        • 6.2.3.3. Platinum Chromium
        • 6.2.3.4. Nickel Titanium
        • 6.2.3.5. Stainless Steel
        • 6.2.3.6. Other Stents
      • 6.2.4. Global Vascular Stents Region
        • 6.2.4.1. South America
          • 6.2.4.1.1. Brazil
          • 6.2.4.1.2. Argentina
          • 6.2.4.1.3. Rest of South America
        • 6.2.4.2. Asia Pacific
          • 6.2.4.2.1. China
          • 6.2.4.2.2. Japan
          • 6.2.4.2.3. India
          • 6.2.4.2.4. South Korea
          • 6.2.4.2.5. Taiwan
          • 6.2.4.2.6. Australia
          • 6.2.4.2.7. Rest of Asia-Pacific
        • 6.2.4.3. Europe
          • 6.2.4.3.1. Germany
          • 6.2.4.3.2. France
          • 6.2.4.3.3. Italy
          • 6.2.4.3.4. United Kingdom
          • 6.2.4.3.5. Netherlands
          • 6.2.4.3.6. Rest of Europe
        • 6.2.4.4. MEA
          • 6.2.4.4.1. Middle East
          • 6.2.4.4.2. Africa
        • 6.2.4.5. North America
          • 6.2.4.5.1. United States
          • 6.2.4.5.2. Canada
          • 6.2.4.5.3. Mexico
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. Vascular Stents: by Type(USD Million)
  • Table 2. Vascular Stents Coronary Stents , by Region USD Million (2014-2019)
  • Table 3. Vascular Stents Peripheral Stents , by Region USD Million (2014-2019)
  • Table 4. Vascular Stents Carotid Stents , by Region USD Million (2014-2019)
  • Table 5. Vascular Stents Renal Artery Stents , by Region USD Million (2014-2019)
  • Table 6. Vascular Stents Femoral Stents , by Region USD Million (2014-2019)
  • Table 7. Vascular Stents Iliac Stents , by Region USD Million (2014-2019)
  • Table 8. Vascular Stents Other Peripheral stents , by Region USD Million (2014-2019)
  • Table 9. Vascular Stents EVAR Stent Grafts , by Region USD Million (2014-2019)
  • Table 10. Vascular Stents Abdominal Aortic Aneurysm , by Region USD Million (2014-2019)
  • Table 11. Vascular Stents Thoracic Aortic Aneurysm , by Region USD Million (2014-2019)
  • Table 12. Vascular Stents: by Application(USD Million)
  • Table 13. Vascular Stents Hospital , by Region USD Million (2014-2019)
  • Table 14. Vascular Stents Clinic , by Region USD Million (2014-2019)
  • Table 15. Vascular Stents: by Material(USD Million)
  • Table 16. Vascular Stents Metallic Stents , by Region USD Million (2014-2019)
  • Table 17. Vascular Stents Cobalt-Chromium , by Region USD Million (2014-2019)
  • Table 18. Vascular Stents Platinum Chromium , by Region USD Million (2014-2019)
  • Table 19. Vascular Stents Nickel Titanium , by Region USD Million (2014-2019)
  • Table 20. Vascular Stents Stainless Steel , by Region USD Million (2014-2019)
  • Table 21. Vascular Stents Other Stents , by Region USD Million (2014-2019)
  • Table 22. South America Vascular Stents, by Country USD Million (2014-2019)
  • Table 23. South America Vascular Stents, by Type USD Million (2014-2019)
  • Table 24. South America Vascular Stents, by Application USD Million (2014-2019)
  • Table 25. South America Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 26. South America Vascular Stents, by Material USD Million (2014-2019)
  • Table 27. Brazil Vascular Stents, by Type USD Million (2014-2019)
  • Table 28. Brazil Vascular Stents, by Application USD Million (2014-2019)
  • Table 29. Brazil Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 30. Brazil Vascular Stents, by Material USD Million (2014-2019)
  • Table 31. Argentina Vascular Stents, by Type USD Million (2014-2019)
  • Table 32. Argentina Vascular Stents, by Application USD Million (2014-2019)
  • Table 33. Argentina Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 34. Argentina Vascular Stents, by Material USD Million (2014-2019)
  • Table 35. Rest of South America Vascular Stents, by Type USD Million (2014-2019)
  • Table 36. Rest of South America Vascular Stents, by Application USD Million (2014-2019)
  • Table 37. Rest of South America Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 38. Rest of South America Vascular Stents, by Material USD Million (2014-2019)
  • Table 39. Asia Pacific Vascular Stents, by Country USD Million (2014-2019)
  • Table 40. Asia Pacific Vascular Stents, by Type USD Million (2014-2019)
  • Table 41. Asia Pacific Vascular Stents, by Application USD Million (2014-2019)
  • Table 42. Asia Pacific Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 43. Asia Pacific Vascular Stents, by Material USD Million (2014-2019)
  • Table 44. China Vascular Stents, by Type USD Million (2014-2019)
  • Table 45. China Vascular Stents, by Application USD Million (2014-2019)
  • Table 46. China Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 47. China Vascular Stents, by Material USD Million (2014-2019)
  • Table 48. Japan Vascular Stents, by Type USD Million (2014-2019)
  • Table 49. Japan Vascular Stents, by Application USD Million (2014-2019)
  • Table 50. Japan Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 51. Japan Vascular Stents, by Material USD Million (2014-2019)
  • Table 52. India Vascular Stents, by Type USD Million (2014-2019)
  • Table 53. India Vascular Stents, by Application USD Million (2014-2019)
  • Table 54. India Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 55. India Vascular Stents, by Material USD Million (2014-2019)
  • Table 56. South Korea Vascular Stents, by Type USD Million (2014-2019)
  • Table 57. South Korea Vascular Stents, by Application USD Million (2014-2019)
  • Table 58. South Korea Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 59. South Korea Vascular Stents, by Material USD Million (2014-2019)
  • Table 60. Taiwan Vascular Stents, by Type USD Million (2014-2019)
  • Table 61. Taiwan Vascular Stents, by Application USD Million (2014-2019)
  • Table 62. Taiwan Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 63. Taiwan Vascular Stents, by Material USD Million (2014-2019)
  • Table 64. Australia Vascular Stents, by Type USD Million (2014-2019)
  • Table 65. Australia Vascular Stents, by Application USD Million (2014-2019)
  • Table 66. Australia Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 67. Australia Vascular Stents, by Material USD Million (2014-2019)
  • Table 68. Rest of Asia-Pacific Vascular Stents, by Type USD Million (2014-2019)
  • Table 69. Rest of Asia-Pacific Vascular Stents, by Application USD Million (2014-2019)
  • Table 70. Rest of Asia-Pacific Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 71. Rest of Asia-Pacific Vascular Stents, by Material USD Million (2014-2019)
  • Table 72. Europe Vascular Stents, by Country USD Million (2014-2019)
  • Table 73. Europe Vascular Stents, by Type USD Million (2014-2019)
  • Table 74. Europe Vascular Stents, by Application USD Million (2014-2019)
  • Table 75. Europe Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 76. Europe Vascular Stents, by Material USD Million (2014-2019)
  • Table 77. Germany Vascular Stents, by Type USD Million (2014-2019)
  • Table 78. Germany Vascular Stents, by Application USD Million (2014-2019)
  • Table 79. Germany Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 80. Germany Vascular Stents, by Material USD Million (2014-2019)
  • Table 81. France Vascular Stents, by Type USD Million (2014-2019)
  • Table 82. France Vascular Stents, by Application USD Million (2014-2019)
  • Table 83. France Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 84. France Vascular Stents, by Material USD Million (2014-2019)
  • Table 85. Italy Vascular Stents, by Type USD Million (2014-2019)
  • Table 86. Italy Vascular Stents, by Application USD Million (2014-2019)
  • Table 87. Italy Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 88. Italy Vascular Stents, by Material USD Million (2014-2019)
  • Table 89. United Kingdom Vascular Stents, by Type USD Million (2014-2019)
  • Table 90. United Kingdom Vascular Stents, by Application USD Million (2014-2019)
  • Table 91. United Kingdom Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 92. United Kingdom Vascular Stents, by Material USD Million (2014-2019)
  • Table 93. Netherlands Vascular Stents, by Type USD Million (2014-2019)
  • Table 94. Netherlands Vascular Stents, by Application USD Million (2014-2019)
  • Table 95. Netherlands Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 96. Netherlands Vascular Stents, by Material USD Million (2014-2019)
  • Table 97. Rest of Europe Vascular Stents, by Type USD Million (2014-2019)
  • Table 98. Rest of Europe Vascular Stents, by Application USD Million (2014-2019)
  • Table 99. Rest of Europe Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 100. Rest of Europe Vascular Stents, by Material USD Million (2014-2019)
  • Table 101. MEA Vascular Stents, by Country USD Million (2014-2019)
  • Table 102. MEA Vascular Stents, by Type USD Million (2014-2019)
  • Table 103. MEA Vascular Stents, by Application USD Million (2014-2019)
  • Table 104. MEA Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 105. MEA Vascular Stents, by Material USD Million (2014-2019)
  • Table 106. Middle East Vascular Stents, by Type USD Million (2014-2019)
  • Table 107. Middle East Vascular Stents, by Application USD Million (2014-2019)
  • Table 108. Middle East Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 109. Middle East Vascular Stents, by Material USD Million (2014-2019)
  • Table 110. Africa Vascular Stents, by Type USD Million (2014-2019)
  • Table 111. Africa Vascular Stents, by Application USD Million (2014-2019)
  • Table 112. Africa Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 113. Africa Vascular Stents, by Material USD Million (2014-2019)
  • Table 114. North America Vascular Stents, by Country USD Million (2014-2019)
  • Table 115. North America Vascular Stents, by Type USD Million (2014-2019)
  • Table 116. North America Vascular Stents, by Application USD Million (2014-2019)
  • Table 117. North America Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 118. North America Vascular Stents, by Material USD Million (2014-2019)
  • Table 119. United States Vascular Stents, by Type USD Million (2014-2019)
  • Table 120. United States Vascular Stents, by Application USD Million (2014-2019)
  • Table 121. United States Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 122. United States Vascular Stents, by Material USD Million (2014-2019)
  • Table 123. Canada Vascular Stents, by Type USD Million (2014-2019)
  • Table 124. Canada Vascular Stents, by Application USD Million (2014-2019)
  • Table 125. Canada Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 126. Canada Vascular Stents, by Material USD Million (2014-2019)
  • Table 127. Mexico Vascular Stents, by Type USD Million (2014-2019)
  • Table 128. Mexico Vascular Stents, by Application USD Million (2014-2019)
  • Table 129. Mexico Vascular Stents, by Mode of Delivery USD Million (2014-2019)
  • Table 130. Mexico Vascular Stents, by Material USD Million (2014-2019)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Vascular Stents: by Type(USD Million)
  • Table 142. Vascular Stents Coronary Stents , by Region USD Million (2020-2025)
  • Table 143. Vascular Stents Peripheral Stents , by Region USD Million (2020-2025)
  • Table 144. Vascular Stents Carotid Stents , by Region USD Million (2020-2025)
  • Table 145. Vascular Stents Renal Artery Stents , by Region USD Million (2020-2025)
  • Table 146. Vascular Stents Femoral Stents , by Region USD Million (2020-2025)
  • Table 147. Vascular Stents Iliac Stents , by Region USD Million (2020-2025)
  • Table 148. Vascular Stents Other Peripheral stents , by Region USD Million (2020-2025)
  • Table 149. Vascular Stents EVAR Stent Grafts , by Region USD Million (2020-2025)
  • Table 150. Vascular Stents Abdominal Aortic Aneurysm , by Region USD Million (2020-2025)
  • Table 151. Vascular Stents Thoracic Aortic Aneurysm , by Region USD Million (2020-2025)
  • Table 152. Vascular Stents: by Application(USD Million)
  • Table 153. Vascular Stents Hospital , by Region USD Million (2020-2025)
  • Table 154. Vascular Stents Clinic , by Region USD Million (2020-2025)
  • Table 155. Vascular Stents: by Material(USD Million)
  • Table 156. Vascular Stents Metallic Stents , by Region USD Million (2020-2025)
  • Table 157. Vascular Stents Cobalt-Chromium , by Region USD Million (2020-2025)
  • Table 158. Vascular Stents Platinum Chromium , by Region USD Million (2020-2025)
  • Table 159. Vascular Stents Nickel Titanium , by Region USD Million (2020-2025)
  • Table 160. Vascular Stents Stainless Steel , by Region USD Million (2020-2025)
  • Table 161. Vascular Stents Other Stents , by Region USD Million (2020-2025)
  • Table 162. South America Vascular Stents, by Country USD Million (2020-2025)
  • Table 163. South America Vascular Stents, by Type USD Million (2020-2025)
  • Table 164. South America Vascular Stents, by Application USD Million (2020-2025)
  • Table 165. South America Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 166. South America Vascular Stents, by Material USD Million (2020-2025)
  • Table 167. Brazil Vascular Stents, by Type USD Million (2020-2025)
  • Table 168. Brazil Vascular Stents, by Application USD Million (2020-2025)
  • Table 169. Brazil Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 170. Brazil Vascular Stents, by Material USD Million (2020-2025)
  • Table 171. Argentina Vascular Stents, by Type USD Million (2020-2025)
  • Table 172. Argentina Vascular Stents, by Application USD Million (2020-2025)
  • Table 173. Argentina Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 174. Argentina Vascular Stents, by Material USD Million (2020-2025)
  • Table 175. Rest of South America Vascular Stents, by Type USD Million (2020-2025)
  • Table 176. Rest of South America Vascular Stents, by Application USD Million (2020-2025)
  • Table 177. Rest of South America Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 178. Rest of South America Vascular Stents, by Material USD Million (2020-2025)
  • Table 179. Asia Pacific Vascular Stents, by Country USD Million (2020-2025)
  • Table 180. Asia Pacific Vascular Stents, by Type USD Million (2020-2025)
  • Table 181. Asia Pacific Vascular Stents, by Application USD Million (2020-2025)
  • Table 182. Asia Pacific Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 183. Asia Pacific Vascular Stents, by Material USD Million (2020-2025)
  • Table 184. China Vascular Stents, by Type USD Million (2020-2025)
  • Table 185. China Vascular Stents, by Application USD Million (2020-2025)
  • Table 186. China Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 187. China Vascular Stents, by Material USD Million (2020-2025)
  • Table 188. Japan Vascular Stents, by Type USD Million (2020-2025)
  • Table 189. Japan Vascular Stents, by Application USD Million (2020-2025)
  • Table 190. Japan Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 191. Japan Vascular Stents, by Material USD Million (2020-2025)
  • Table 192. India Vascular Stents, by Type USD Million (2020-2025)
  • Table 193. India Vascular Stents, by Application USD Million (2020-2025)
  • Table 194. India Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 195. India Vascular Stents, by Material USD Million (2020-2025)
  • Table 196. South Korea Vascular Stents, by Type USD Million (2020-2025)
  • Table 197. South Korea Vascular Stents, by Application USD Million (2020-2025)
  • Table 198. South Korea Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 199. South Korea Vascular Stents, by Material USD Million (2020-2025)
  • Table 200. Taiwan Vascular Stents, by Type USD Million (2020-2025)
  • Table 201. Taiwan Vascular Stents, by Application USD Million (2020-2025)
  • Table 202. Taiwan Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 203. Taiwan Vascular Stents, by Material USD Million (2020-2025)
  • Table 204. Australia Vascular Stents, by Type USD Million (2020-2025)
  • Table 205. Australia Vascular Stents, by Application USD Million (2020-2025)
  • Table 206. Australia Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 207. Australia Vascular Stents, by Material USD Million (2020-2025)
  • Table 208. Rest of Asia-Pacific Vascular Stents, by Type USD Million (2020-2025)
  • Table 209. Rest of Asia-Pacific Vascular Stents, by Application USD Million (2020-2025)
  • Table 210. Rest of Asia-Pacific Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 211. Rest of Asia-Pacific Vascular Stents, by Material USD Million (2020-2025)
  • Table 212. Europe Vascular Stents, by Country USD Million (2020-2025)
  • Table 213. Europe Vascular Stents, by Type USD Million (2020-2025)
  • Table 214. Europe Vascular Stents, by Application USD Million (2020-2025)
  • Table 215. Europe Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 216. Europe Vascular Stents, by Material USD Million (2020-2025)
  • Table 217. Germany Vascular Stents, by Type USD Million (2020-2025)
  • Table 218. Germany Vascular Stents, by Application USD Million (2020-2025)
  • Table 219. Germany Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 220. Germany Vascular Stents, by Material USD Million (2020-2025)
  • Table 221. France Vascular Stents, by Type USD Million (2020-2025)
  • Table 222. France Vascular Stents, by Application USD Million (2020-2025)
  • Table 223. France Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 224. France Vascular Stents, by Material USD Million (2020-2025)
  • Table 225. Italy Vascular Stents, by Type USD Million (2020-2025)
  • Table 226. Italy Vascular Stents, by Application USD Million (2020-2025)
  • Table 227. Italy Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 228. Italy Vascular Stents, by Material USD Million (2020-2025)
  • Table 229. United Kingdom Vascular Stents, by Type USD Million (2020-2025)
  • Table 230. United Kingdom Vascular Stents, by Application USD Million (2020-2025)
  • Table 231. United Kingdom Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 232. United Kingdom Vascular Stents, by Material USD Million (2020-2025)
  • Table 233. Netherlands Vascular Stents, by Type USD Million (2020-2025)
  • Table 234. Netherlands Vascular Stents, by Application USD Million (2020-2025)
  • Table 235. Netherlands Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 236. Netherlands Vascular Stents, by Material USD Million (2020-2025)
  • Table 237. Rest of Europe Vascular Stents, by Type USD Million (2020-2025)
  • Table 238. Rest of Europe Vascular Stents, by Application USD Million (2020-2025)
  • Table 239. Rest of Europe Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 240. Rest of Europe Vascular Stents, by Material USD Million (2020-2025)
  • Table 241. MEA Vascular Stents, by Country USD Million (2020-2025)
  • Table 242. MEA Vascular Stents, by Type USD Million (2020-2025)
  • Table 243. MEA Vascular Stents, by Application USD Million (2020-2025)
  • Table 244. MEA Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 245. MEA Vascular Stents, by Material USD Million (2020-2025)
  • Table 246. Middle East Vascular Stents, by Type USD Million (2020-2025)
  • Table 247. Middle East Vascular Stents, by Application USD Million (2020-2025)
  • Table 248. Middle East Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 249. Middle East Vascular Stents, by Material USD Million (2020-2025)
  • Table 250. Africa Vascular Stents, by Type USD Million (2020-2025)
  • Table 251. Africa Vascular Stents, by Application USD Million (2020-2025)
  • Table 252. Africa Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 253. Africa Vascular Stents, by Material USD Million (2020-2025)
  • Table 254. North America Vascular Stents, by Country USD Million (2020-2025)
  • Table 255. North America Vascular Stents, by Type USD Million (2020-2025)
  • Table 256. North America Vascular Stents, by Application USD Million (2020-2025)
  • Table 257. North America Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 258. North America Vascular Stents, by Material USD Million (2020-2025)
  • Table 259. United States Vascular Stents, by Type USD Million (2020-2025)
  • Table 260. United States Vascular Stents, by Application USD Million (2020-2025)
  • Table 261. United States Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 262. United States Vascular Stents, by Material USD Million (2020-2025)
  • Table 263. Canada Vascular Stents, by Type USD Million (2020-2025)
  • Table 264. Canada Vascular Stents, by Application USD Million (2020-2025)
  • Table 265. Canada Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 266. Canada Vascular Stents, by Material USD Million (2020-2025)
  • Table 267. Mexico Vascular Stents, by Type USD Million (2020-2025)
  • Table 268. Mexico Vascular Stents, by Application USD Million (2020-2025)
  • Table 269. Mexico Vascular Stents, by Mode of Delivery USD Million (2020-2025)
  • Table 270. Mexico Vascular Stents, by Material USD Million (2020-2025)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vascular Stents: by Type USD Million (2014-2019)
  • Figure 5. Global Vascular Stents: by Application USD Million (2014-2019)
  • Figure 6. Global Vascular Stents: by Material USD Million (2014-2019)
  • Figure 7. South America Vascular Stents Share (%), by Country
  • Figure 8. Asia Pacific Vascular Stents Share (%), by Country
  • Figure 9. Europe Vascular Stents Share (%), by Country
  • Figure 10. MEA Vascular Stents Share (%), by Country
  • Figure 11. North America Vascular Stents Share (%), by Country
  • Figure 12. Global Vascular Stents share by Players 2019 (%)
  • Figure 13. Global Vascular Stents share by Players (Top 3) 2019(%)
  • Figure 14. Global Vascular Stents share by Players (Top 5) 2019(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 17. Medtronic plc (Ireland) Revenue: by Geography 2019
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2019
  • Figure 20. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Boston Scientific Corporation (United States) Revenue: by Geography 2019
  • Figure 22. BIOTRONIK SE & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 23. BIOTRONIK SE & Co. KG (Germany) Revenue: by Geography 2019
  • Figure 24. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. B. Braun Melsungen AG (Germany) Revenue: by Geography 2019
  • Figure 26. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Terumo Corporation (Japan) Revenue: by Geography 2019
  • Figure 28. STENTYS SA (France) Revenue, Net Income and Gross profit
  • Figure 29. STENTYS SA (France) Revenue: by Geography 2019
  • Figure 30. MicroPort Scientific Corporation (China) Revenue, Net Income and Gross profit
  • Figure 31. MicroPort Scientific Corporation (China) Revenue: by Geography 2019
  • Figure 32. Meril Life Sciences Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 33. Meril Life Sciences Pvt. Ltd. (India) Revenue: by Geography 2019
  • Figure 34. Vascular Concepts (India) Revenue, Net Income and Gross profit
  • Figure 35. Vascular Concepts (India) Revenue: by Geography 2019
  • Figure 36. Global Vascular Stents: by Type USD Million (2020-2025)
  • Figure 37. Global Vascular Stents: by Application USD Million (2020-2025)
  • Figure 38. Global Vascular Stents: by Material USD Million (2020-2025)
  • Figure 39. South America Vascular Stents Share (%), by Country
  • Figure 40. Asia Pacific Vascular Stents Share (%), by Country
  • Figure 41. Europe Vascular Stents Share (%), by Country
  • Figure 42. MEA Vascular Stents Share (%), by Country
  • Figure 43. North America Vascular Stents Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Medtronic plc (Ireland)
  • Abbott Laboratories (United States)
  • Boston Scientific Corporation (United States)
  • BIOTRONIK SE & Co. KG (Germany)
  • B. Braun Melsungen AG (Germany)
  • Terumo Corporation (Japan)
  • STENTYS SA (France)
  • MicroPort Scientific Corporation (China)
  • Meril Life Sciences Pvt. Ltd. (India)
  • Vascular Concepts (India)
Additional players considered in the study are as follows:
C. R. Bard (United States) , Endologix Inc. (United States) , Lombard Medical Technologies (United Kingdom) , Translumina GmbH (Germany) , JOTEC GmbH (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation